Eugenol/OVA is an antigen-adjuvant conjugate of Eugenol and chicken ovalbumin (OVA). This conjugation enhances the production of antigen-specific antibodies in vaccine models by linking the antigen to a protein adjuvant. The conjugate does not affect protein folding or disrupt major epitopes and can improve cross-presentation and the generation of antigen-specific T cells.